Jonathan Abramowitz Explained

Jonathan Abramowitz
Birth Name:Jonathan Stuart Abramowitz
Birth Date:11 June 1969
Birth Place:Baltimore, Maryland, U.S.
Occupation:Clinical psychologist, professor, researcher, author
Organization:University of North Carolina at Chapel Hill
Known For:Expertise in the treatment and study of OCD and anxiety disorders
Image Size:150

Jonathan Stuart Abramowitz (born June 11, 1969) is an American clinical psychologist and Professor in the Department of Psychology and Neuroscience at the University of North Carolina at Chapel Hill (UNC-CH).[1] He is an expert on obsessive-compulsive disorder (OCD) and anxiety disorders whose work is highly cited.[2] He maintains a research lab and currently serves as the Director of the UNC-CH Clinical Psychology PhD Program. Abramowitz approaches the understanding and treatment of psychological problems from a cognitive-behavioral perspective.

Academic career

Abramowitz earned his B.A. in Psychology from Muhlenberg College in 1991, his M.A. in Psychology from Bucknell University in 1993, and his Ph.D. in Clinical Psychology from the University of Memphis in 1998. He completed both a predoctoral internship and postdoctoral fellowship at the Center for Treatment and Study of Anxiety at the University of Pennsylvania. He was a staff psychologist and Associate Professor at the Mayo Clinic (Rochester, Minnesota) from 2000 until 2006. He moved to North Carolina in the summer of 2006.

Abramowitz's research focuses on the development and evaluation of cognitive-behavioral treatments (CBT) for OCD and other anxiety-related problems, as well as on understanding the nature and psychopathology of these problems. He is the author of approximately 300 publications, including more than 10 books and over 250 peer reviewed journal articles and book chapters. He has also worked extensively as a book and journal editor. Abramowitz has given invited lectures around the world and served in numerous editorial and advisory roles for scientific journals and organizations.

Abramowitz is board certified by the American Board of Behavioral Psychology and is a licensed psychologist in North Carolina. In his clinical practice, he specializes in providing outpatient consultation and cognitive-behavioral treatment of OCD and other anxiety-related problems.

Research areas and contributions

Treatment of OCD and anxiety: A major focus of Abramowitz's research is the treatment of OCD. His work primarily addresses exposure and response prevention (ERP; a form of cognitive-behavioral therapy [CBT]) and he has conducted treatment outcome studies and meta-analytic reviews of this therapy.[3] [4] He has also investigated factors that predict good and poor outcomes.[5] [6]

Abramowitz has helped to develop an OCD treatment program combining ERP with Acceptance and Commitment Therapy (ACT).[7] He has also helped to develop couple-based ERP programs for OCD and Body Dysmorphic Disorder.[8]

Abramowitz has written about, and is conducting research to better understand, how to enhance the outcome of exposure therapy/ERP by optimizing extinction learning.[9] [10] [11] This work is drawn from inhibitory learning models of exposure.

Nature and symptoms of OCD: Abramowitz's research also focuses on trying to understand the complex symptomatology of OCD.[12] His work has identified 4 subtypes/dimensions of this disorder that involve somewhat distinct cognitive and behavioral phenomena: (a) contamination, (b) responsibility for harm/mistakes, (c) unacceptable thoughts, and (d) incompleteness/symmetry.[13] He has also contributed to the re-conceptualization of hoarding as separate from OCD.[14]

Abramowitz has argued that OCD symptoms lie on a continuum with normal everyday experiences, and that one’s learning history (and to a lesser extent, their biology) influence the frequency, intensity, and duration of OCD symptoms.[15] [16] He has also criticized the DSM-5’s re-classification of OCD as separate from the anxiety disorders and as overlapping with conditions such as Hair Pulling Disorder and Skin Picking Disorder.[17] Abramowitz is generally critical of biomedical models which view problems such as OCD and anxiety as brain diseases or genetic disorders.[18]

Assessment of OCD: Abramowitz led a team of researchers in 2010 that developed the Dimensional Obsessive-Compulsive Scale (DOCS), a 20-item self-report instrument designed to measure the severity of the four types of OCD symptoms (see above).[19] The DOCS has been translated into multiple languages for use worldwide.[20] [21] [22] [23]

Cognitive-behavioral factors and models of OCD and anxiety: The cognitive-behavioral model is the leading conceptual approach to understanding OCD and anxiety disorders.[24] [25] Abramowitz conducts cross-sectional, experimental, and prospective (longitudinal) research that has helped to clarify and advance this conceptual model. His work focuses on cognitive biases such as anxiety sensitivity,[26] thought-action fusion,[27] intolerance of uncertainty,[28] and attentional biases[29] that factor in the persistence of OCD and irrational fear. With his team at UNC, he has developed experimental paradigms for studying thought-action fusion and intolerance of uncertainty.[30] [31] His work has also demonstrated that cognitive factors prospectively predict the escalation of intrusive thoughts into obsessions.[32]

Abramowitz also conducts studies on cognitive-behavioral factors in other anxiety and related problems, including health/illness anxiety, shy bladder syndrome, panic disorder, and hoarding.[33] [34] [35]

Scrupulosity: Abramowitz has conducted studies on, and developed a cognitive-behavioral model of, scrupulosity (religious obsessions and compulsions).[36] He also developed the Penn Inventory of Scrupulosity (PIOS) to measure this phenomenon.[37]

Prevention of postpartum OCD: Abramowitz developed and evaluated a prevention program for OCD symptoms in new parents.[38] This work was derived from previous studies led by Abramowitz showing that certain types of cognitive/psychological phenomena (such as the tendency to catastrophically misinterpret unwanted thoughts) predict the development of OCD symptoms in the postpartum. The prevention program, known as "Baby PREP", can be delivered as part of perinatal education classes and was shown to be more effective than a credible placebo control program in preventing OCD symptoms among vulnerable expecting/new parents.

Cross-cultural factors: Abramowitz has conducted research on cultural, religious, and racial differences in the expression of anxiety and OCD symptoms and related phenomena.[39] He is part of a multi-national collaborative effort studying the nature of intrusive obsessional thoughts in cultures and countries around the world.[40] [41] [42]

Awards, recognition, and leadership

Abramowitz's contributions to the fields of OCD, anxiety disorders, and clinical psychology are recognized by his colleagues, peers, and the media through numerous honors, awards, and appearances. He is a Fellow and Past President of the Association for Behavioral and Cognitive Therapies (ABCT)[43] [44] and serves on the International OCD Foundation Scientific and Clinical Advisory Board.[45] He is the recipient of a Muhlenberg College Alumni Achievement Award,[46] the David Shakow Early Career Award for Outstanding Contributions to the Science and Practice of Clinical Psychology (from Division 12 of the American Psychological Association),[47] and the Mayo Clinic Department of Psychiatry and Psychology Outstanding Contributions to Research Award.

Abramowitz has served on the Editorial Boards of several scientific journals and as Associate Editor of Journal of Cognitive Psychotherapy (2008–present) and Associate Editor of Behaviour Research and Therapy (2006-2015). He is the Editor-in-Chief of the Journal of Obsessive-Compulsive and Related Disorders. His ResearchGate score is higher than 97.5% of this site's members.[48]

Abramowitz was invited by colleagues in Norway to help train and supervise 30 OCD treatment teams in that country. The training is part of an initiative funded by the Norwegian government to ensure that all individuals with OCD in Norway have access to effective treatment.[49]

Abramowitz has twice been appointed as Associate Chair of the University of North Carolina at Chapel Hill Department of Psychology and Neuroscience, a position he held from 2007-2017.

Selected works

Books

Journal articles

External links

Notes and References

  1. Web site: Core Faculty Department Of Psychology and Neuroscience. psychology.unc.edu. 2015-11-22.
  2. Web site: Jonathan S. Abramowitz - Google Scholar Citations. scholar.google.com. 2015-11-22.
  3. Exposure and ritual prevention for obsessive-compulsive disorder: Effects of intensive versus twice-weekly sessions.. Journal of Consulting and Clinical Psychology. 394–398. 71. 2. 10.1037/0022-006x.71.2.394. Jonathan S.. Abramowitz. Edna B.. Foa. Martin E.. Franklin. 11121137. 12699033. 2003.
  4. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative Review.. Journal of Consulting and Clinical Psychology. 44–52. 65. 1. 10.1037/0022-006x.65.1.44. Jonathan S.. Abramowitz. 20859800. 9103733. 1997.
  5. Symptom Presentation and Outcome of Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder.. Journal of Consulting and Clinical Psychology. 1049–1057. 71. 6. 10.1037/0022-006x.71.6.1049. Jonathan S.. Abramowitz. Martin E.. Franklin. Stefanie A.. Schwartz. Jami M.. Furr. 10615562. 14622080. 2003.
  6. Effects of comorbid depression on response to treatment for obsessive-compulsive disorder. Behavior Therapy. 2000-01-01. 517–528. 31. 3. 10.1016/S0005-7894(00)80028-3. Jonathan S.. Abramowitz. Martin E.. Franklin. Gordon P.. Street. Michael J.. Kozak. Edna B.. Foa.
  7. Exposure therapy for OCD from an acceptance and commitment therapy (ACT) framework. Journal of Obsessive-Compulsive and Related Disorders. 167–173. 6. 10.1016/j.jocrd.2014.12.007. Michael P.. Twohig. Jonathan S.. Abramowitz. Ellen J.. Bluett. Laura E.. Fabricant. Ryan J.. Jacoby. Kate L.. Morrison. Lillian. Reuman. Brooke M.. Smith. 2015.
  8. Treating Obsessive-Compulsive Disorder in Intimate Relationships: A Pilot Study of Couple-Based Cognitive-Behavior Therapy. Behavior Therapy. 395–407. 44. 3. 10.1016/j.beth.2013.02.005. Jonathan S.. Abramowitz. Donald H.. Baucom. Sara. Boeding. Michael G.. Wheaton. Nicole D.. Pukay-Martin. Laura E.. Fabricant. Christine. Paprocki. Melanie S.. Fischer. 23768667. 2013.
  9. Strategies for Improving Long-Term Outcomes in Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder: Insights From Learning Theory. Cognitive and Behavioral Practice. 2014-02-01. 20–31. 21. 1. 10.1016/j.cbpra.2013.06.004. Jonathan S.. Abramowitz. Joanna J.. Arch.
  10. Web site: The practice of exposure therapy%3A Relevance of cognitive-behavioral theory and extinction theory - Google Scholar. scholar.google.com. 2015-11-22.
  11. Jacoby. Ryan J.. Abramowitz. Jonathan S.. Inhibitory learning approaches to exposure therapy: A critical review and translation to obsessive-compulsive disorder. Clinical Psychology Review. 49. 28–40. 10.1016/j.cpr.2016.07.001. 27521505. 2016.
  12. Obsessive-compulsive disorder. The Lancet. 491–499. 374. 9688. 10.1016/s0140-6736(09)60240-3. Jonathan S. Abramowitz. Steven. Taylor. Dean. McKay. 19665647. Aug 2009. 203833429.
  13. The relationship between obsessive beliefs and symptom dimensions in obsessive-compulsive disorder. Behaviour Research and Therapy. 2010-10-01. 949–954. 48. 10. 10.1016/j.brat.2010.05.027. 20800750. Michael G.. Wheaton. Jonathan S.. Abramowitz. Noah C.. Berman. Bradley C.. Riemann. Lisa R.. Hale.
  14. The status of hoarding as a symptom of obsessive–compulsive disorder. Behaviour Research and Therapy. 2008-09-01. 1026–1033. 46. 9. 10.1016/j.brat.2008.05.006. Jonathan S.. Abramowitz. Michael G.. Wheaton. Eric A.. Storch. 18684434.
  15. Book: Abramowitz, Jonathan S.. Understanding and Treating Obsessive-compulsive Disorder: A Cognitive Behavioral Approach. Lawrence Erlbaum Associates. 2006-01-01. 9780805851847.
  16. The relevance of analogue studies for understanding obsessions and compulsions. Clinical Psychology Review. 2014-04-01. 206–217. 34. 3. 10.1016/j.cpr.2014.01.004. Jonathan S.. Abramowitz. Laura E.. Fabricant. Steven. Taylor. Brett J.. Deacon. Dean. McKay. Eric A.. Storch. 24561743.
  17. Obsessive-Compulsive and Related Disorders: A Critical Review of the New Diagnostic Class. Annual Review of Clinical Psychology. 2015-01-01. 25581239. 165–186. 11. 1. 10.1146/annurev-clinpsy-032813-153713. Jonathan S.. Abramowitz. Ryan J.. Jacoby. 45823266. free.
  18. Web site: Abramowitz. Jonathan. October 2015. The biomedical model: Caveat emptor. dead. https://web.archive.org/web/20170902035906/http://www.abct.org/docs/PastIssue/38n7.pdf. 2 September 2017. 22 November 2015. Past issues of the Behavior Therapist. Association for Behavioral and Cognitive Therapies.
  19. Assessment of obsessive-compulsive symptom dimensions: Development and evaluation of the Dimensional Obsessive-Compulsive Scale.. Psychological Assessment. 180–198. 22. 1. 10.1037/a0018260. Jonathan S.. Abramowitz. Brett J.. Deacon. Bunmi O.. Olatunji. Michael G.. Wheaton. Noah C.. Berman. Diane. Losardo. Kiara R.. Timpano. Patrick B.. McGrath. Bradley C.. Riemann. 7206349. 20230164. 2010.
  20. The Icelandic version of the dimensional obsessive compulsive scale (DOCS) and its relationship with obsessive beliefs. Journal of Obsessive-Compulsive and Related Disorders. 149–156. 2. 2. 10.1016/j.jocrd.2013.02.001. Ragnar P.. Ólafsson. Jóhann B.. Arngrímsson. Páll. Árnason. Þráinn. Kolbeinsson. Paul M.G.. Emmelkamp. Árni. Kristjánsson. Daníel Þ.. Ólason. 2013.
  21. Spanish version of the Dimensional Obsessive–Compulsive Scale (DOCS): Psychometric properties and relation to obsessive beliefs. Comprehensive Psychiatry. 206–214. 55. 1. 10.1016/j.comppsych.2013.08.015. 24209609. Clara. López-Solà. Fernando. Gutiérrez. Pino. Alonso. Silvia. Rosado. Joan. Taberner. Cinto. Segalàs. Eva. Real. José Manuel. Menchón. Miquel A.. Fullana. 2014.
  22. Factor Congruence and Psychometric Properties of the Italian Version of the Dimensional Obsessive-Compulsive Scale (DOCS) Across Non-Clinical and Clinical Samples. Journal of Psychopathology and Behavioral Assessment. 2014-08-03. 0882-2689. 329–339. 37. 2. 10.1007/s10862-014-9450-1. Gabriele. Melli. Carlo. Chiorri. Francesco. Bulli. Claudia. Carraresi. Eleonora. Stopani. Jonathan. Abramowitz. 145758458.
  23. A Validation Study of the Korean-Version of the Dimensional Obsessive-Compulsive Scale. Journal of Korean Neuropsychiatric Association. 52. 3. 10.4306/jknpa.2013.52.3.130. Hae Won. Kim. Jee In. Kang. Seung Jun. Kim. Kyungun. Jhung. Eun Joo. Kim. Se Joo. Kim. 130. 2013. free.
  24. Understanding and treating obsessive—compulsive disorder. Behaviour Research and Therapy. 1999-07-01. S29–S52. 37, Supplement 1. 10.1016/S0005-7967(99)00049-2. Paul M.. Salkovskis. 13020064 .
  25. Anxiety disorders: why they persist and how to treat them. Behaviour Research and Therapy. 1999-07-01. 0005-7967. 10402694. S5–27. 37. D. M.. Clark. Suppl 1 . 10.1016/s0005-7967(99)00048-0.
  26. Dimensions of anxiety sensitivity in the anxiety disorders: Evaluation of the ASI-3. Journal of Anxiety Disorders. 401–408. 26. 3. 10.1016/j.janxdis.2012.01.002. 22306133. Michael G.. Wheaton. Brett J.. Deacon. Patrick B.. McGrath. Noah C.. Berman. Jonathan S.. Abramowitz. 2012.
  27. The effects of familiarity on thought–action fusion. Behaviour Research and Therapy. 2011-10-01. 695–699. 49. 10. 10.1016/j.brat.2011.07.010. 21835394. Noah C.. Berman. Michael G.. Wheaton. Laura E.. Fabricant. Spenser R.. Jacobson. Jonathan S.. Abramowitz.
  28. Just to be certain: Confirming the factor structure of the Intolerance of Uncertainty Scale in patients with obsessive-compulsive disorder. Journal of Anxiety Disorders. 535–542. 27. 5. 10.1016/j.janxdis.2013.07.008. 23973743. Ryan J.. Jacoby. Laura E.. Fabricant. Rachel C.. Leonard. Bradley C.. Riemann. Jonathan S.. Abramowitz. 2013.
  29. Examining Attentional Bias in Scrupulosity: Null Findings From the Dot Probe Paradigm. Journal of Cognitive Psychotherapy. 2015-11-01. 302–314. 29. 4. 10.1891/0889-8391.29.4.302. Ryan J.. Jacoby. Noah C.. Berman. Robert. Graziano. Jonathan S.. Abramowitz. 32755940. 52200432.
  30. Evaluation of an In Vivo Measure of Thought–Action Fusion. Journal of Cognitive Psychotherapy. 2011-05-01. 155–164. 25. 2. 10.1891/0889-8391.25.2.155. Noah C.. Berman. Jonathan S.. Abramowitz. Michael G.. Wheaton. Caleb. Pardue. Laura. Fabricant. 145677293.
  31. How is the Beads Task related to intolerance of uncertainty in anxiety disorders?. Journal of Anxiety Disorders. 495–503. 28. 6. 10.1016/j.janxdis.2014.05.005. 24930046. Ryan J.. Jacoby. Jonathan S.. Abramowitz. Benjamin E.. Buck. Laura E.. Fabricant. 2014.
  32. The role of cognitive factors in the pathogenesis of obsessive–compulsive symptoms: A prospective study. Behaviour Research and Therapy. 2006-09-01. 1361–1374. 44. 9. 10.1016/j.brat.2005.09.011. Jonathan S.. Abramowitz. Maheruh. Khandker. Christy A.. Nelson. Brett J.. Deacon. Rebecca. Rygwall. 16352291.
  33. Tracing "Fearbola": Psychological Predictors of Anxious Responding to the Threat of Ebola. Cognitive Therapy and Research. 2015-06-19. 0147-5916. 816–825. 39. 6. 10.1007/s10608-015-9701-9. Shannon M.. Blakey. Lillian. Reuman. Ryan J.. Jacoby. Jonathan S.. Abramowitz. 32214559. 7088101.
  34. Development and Validation of the Shy Bladder Scale. Cognitive Behaviour Therapy. 2012-09-01. 1650-6073. 22452544. 251–260. 41. 3. 10.1080/16506073.2012.658852. Brett J.. Deacon. James J.. Lickel. Jonathan S.. Abramowitz. Patrick B.. McGrath. 34747567.
  35. Experiential Avoidance and Saving Cognitions in the Prediction of Hoarding Symptoms. Cognitive Therapy and Research. 2010-10-16. 0147-5916. 511–516. 35. 6. 10.1007/s10608-010-9338-7. Michael G.. Wheaton. Jonathan S.. Abramowitz. Joseph C.. Franklin. Noah C.. Berman. Laura E.. Fabricant. 419377.
  36. Scrupulosity: A cognitive–behavioral analysis and implications for treatment. Journal of Obsessive-Compulsive and Related Disorders. 140–149. 3. 2. 10.1016/j.jocrd.2013.12.007. Jonathan S.. Abramowitz. Ryan J.. Jacoby. 2014.
  37. Religious obsessions and compulsions in a non-clinical sample: the Penn Inventory of Scrupulosity (PIOS). Behaviour Research and Therapy. 2002-07-01. 825–838. 40. 7. 10.1016/S0005-7967(01)00070-5. Jonathan S. Abramowitz. Jonathan. D. Huppert. Adam B. Cohen. David F. Tolin. Shawn P. Cahill. 12074376.
  38. Efficacy of a prevention program for postpartum obsessive–compulsive symptoms. Journal of Psychiatric Research. 1511–1517. 45. 11. 10.1016/j.jpsychires.2011.06.015. 21764404. Kiara R.. Timpano. Jonathan S.. Abramowitz. Brittain L.. Mahaffey. Melissa A.. Mitchell. Norman B.. Schmidt. 2011.
  39. Differences in Obsessive–Compulsive Symptoms and Obsessive Beliefs: A Comparison between African Americans, Asian Americans, Latino Americans, and European Americans. Cognitive Behaviour Therapy. 2013-03-01. 1650-6073. 23134374. 9–20. 42. 1. 10.1080/16506073.2012.701663. Michael G.. Wheaton. Noah C.. Berman. Laura E.. Fabricant. Jonathan S.. Abramowitz. 44356328.
  40. Part 1—You can run but you can't hide: Intrusive thoughts on six continents. Journal of Obsessive-Compulsive and Related Disorders. 269–279. 3. 3. 10.1016/j.jocrd.2013.09.002. Adam S.. Radomsky. Gillian M.. Alcolado. Jonathan S.. Abramowitz. Pino. Alonso. Amparo. Belloch. Martine. Bouvard. David A.. Clark. Meredith E.. Coles. Guy. Doron. 2014.
  41. Part 2. They scare because we care: The relationship between obsessive intrusive thoughts and appraisals and control strategies across 15 cities. Journal of Obsessive-Compulsive and Related Disorders. 280–291. 3. 3. 10.1016/j.jocrd.2014.02.006. Richard. Moulding. Meredith E.. Coles. Jonathan S.. Abramowitz. Gillian M.. Alcolado. Pino. Alonso. Amparo. Belloch. Martine. Bouvard. David A.. Clark. Guy. Doron. 2014.
  42. Part 3. A question of perspective: The association between intrusive thoughts and obsessionality in 11 countries. Journal of Obsessive-Compulsive and Related Disorders. 292–299. 3. 3. 10.1016/j.jocrd.2013.12.006. David A.. Clark. Jon. Abramowitz. Gillian M.. Alcolado. Pino. Alonso. Amparo. Belloch. Martine. Bouvard. Meredith E.. Coles. Guy. Doron. Hector. Fernández-Álvarez. 2014.
  43. Web site: Fellow at ABCT. www.abct.org. 2015-11-22.
  44. Web site: ABCT Association for Behavioral and Cognitive Therapies Cognitive Behavioral Therapy. www.abct.org. 2015-11-22.
  45. Web site: Our Boards. International OCD Foundation. 2015-11-22. en-US.
  46. Web site: MuhlenbergConnect - Award Winners. www.muhlenbergconnect.com. 2015-11-22.
  47. Web site: David Shakow Early Career Award for Distinguished Scientific Contributions to Clinical Psychology . 2015-11-22 . apa.org.
  48. Web site: Jonathan Abramowitz on ResearchGate. 22 November 2015. ResearchGate.
  49. Web site: Dissemination and intensifying evidence-based treatment for OCD: Norway is in the lead.